HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antonella Caputo Selected Research

tat Gene Products (tat Protein)

2/2022Kaposi's Sarcoma Lesion Progression in BKV-Tat Transgenic Mice Is Increased by Inflammatory Cytokines and Blocked by Treatment with Anti-Tat Antibodies.
1/2015Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide.
4/2009Containment of infection in tat vaccinated monkeys after rechallenge with a higher dose of SHIV89.6P(cy243).
1/2008The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: implications for the design of new vaccination strategies against AIDS.
10/2004Recent advances in the development of HIV-1 Tat-based vaccines.
9/2004Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antonella Caputo Research Topics

Disease

15Infections
05/2021 - 09/2002
12Acquired Immunodeficiency Syndrome (AIDS)
02/2022 - 10/2004
5Neoplasms (Cancer)
02/2022 - 09/2003
1Kaposi Sarcoma (Kaposi's Sarcoma)
02/2022
1Melanoma (Melanoma, Malignant)
05/2021
1Reinfection
06/2020
1Chronic Hepatitis C
01/2019
1Pathologic Processes
10/2014
1Parathyroid Neoplasms (Parathyroid Neoplasm)
10/2014
1Adenoma (Adenomas)
10/2014
1Malignant Mesothelioma
01/2014
1Viremia
01/2014
1Mesothelioma
01/2014
1Seizures (Absence Seizure)
07/2013
1Communicable Diseases (Infectious Diseases)
09/2010
1Vesicular Stomatitis
11/2009
1Cystic Fibrosis (Mucoviscidosis)
09/2009
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
05/2009
1Virus Diseases (Viral Diseases)
02/2008
1Herpes Simplex
11/2006
1Disease Progression
10/2004
1Starvation
09/2003
1Necrosis
09/2003

Drug/Important Bio-Agent (IBA)

11VaccinesIBA
02/2022 - 09/2002
6tat Gene Products (tat Protein)IBA
02/2022 - 09/2004
5Proteins (Proteins, Gene)FDA Link
10/2014 - 09/2004
4AntibodiesIBA
02/2022 - 04/2005
3AntigensIBA
01/2008 - 09/2002
2Antiviral Agents (Antivirals)IBA
01/2019 - 01/2013
2AIDS VaccinesIBA
07/2008 - 03/2007
1CytokinesIBA
02/2022
1LipidsIBA
01/2022
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
05/2021
1Protein Subunit VaccinesIBA
05/2021
1B-Lymphocyte Epitopes (B-Cell Epitope)IBA
05/2021
1Therapeutic UsesIBA
06/2020
1CalciumIBA
10/2014
1CateninsIBA
01/2014
1Peptide Hydrolases (Proteases)FDA Link
01/2014
1Immunoglobulin G (IgG)IBA
01/2014
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2014
1Herpes Simplex Virus VaccinesIBA
01/2014
1Kainic Acid (Kainate)IBA
07/2013
1ConvulsantsIBA
07/2013
1Glycoproteins (Glycoprotein)IBA
11/2009
1Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
09/2009
1DystrophinIBA
05/2009
1Antisense OligoribonucleotidesIBA
05/2009
1gag Gene Products (gag Protein)IBA
01/2008
1EpitopesIBA
01/2008
1Oxidants (Oxidizing Agents)IBA
04/2007
1DNA (Deoxyribonucleic Acid)IBA
09/2004
1Transforming Growth Factor beta1 (TGF beta 1)IBA
09/2003

Therapy/Procedure

3Therapeutics
02/2022 - 01/2019
1Microspheres (Microsphere)
01/2014